ChromoSeq™
| Test Details | ChromoSeq™ is a whole genome sequencing assay intended for the comprehensive clinical genomic evaluation of known or suspected hematologic neoplasms including AML and MDS. ChromoSeq™ is capable of unbiased detection of chromosomal translocations, copy number alterations, single nucleotide variants, and insertions/deletions from DNA. The assay can also provide data in the setting of failed or incomplete cytogenetics. |
| Relevant Condition(s) | Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) |
| Methodology | Whole Genome Sequencing |
| Frequency | Batched bi-weekly |
| Turnaround Time | Approximately 21 business days |
| Specimen Requirements | 1.0 mL Peripheral Blood or Bone Marrow Aspirate collected within 14 days |
| Specimen Collection | K2 EDTA vacutainer |
| Minimum Specimen Volume | 0.5 mL Peripheral Blood or Bone Marrow Aspirate |
| Storage/Transport Conditions | Ship at room temperature within 72 hours of collection |
| Unacceptable Conditions | Fresh or FFPE tissue, incorrect specimen container, or unlabeled specimen |
| CPT Code(s) | 81479 |